fulvestrant,lerociclib
Genor Biopharma
['lerociclib', 'mbc', 'breast', ' fulv', 'bcsm']
leonarda-1: phase iii randomized study of lerociclib plus fulvestrant in patients with hr+, her2- locally advanced or metastatic breast cancer that has progressed on prior endocrine therapy. #mbc #asco23 #metastaticbreastcancer #clinicaltrials #bcsm 